Tag Archives: early stage life science

Family Offices Converge on RESI to Meet Early Stage Biotech and Medtech Startups

8 Jun

By Lucy Parkinson, Director of Research, LSN

RESI is a venue where early stage life science startups can meet with investors of every type that are a fit for their company’s technology and stage – and that includes family offices. RESI San Diego features two panels devoted to this elusive investor class – Biotech Family Offices and Medtech Family Offices. Whether you’re developing a novel therapeutic, an innovative device or an improved diagnostic solution, Family Offices can’t be overlooked as a potential source of capital and RESI will provide you with the opportunity to hear advice and insight directly from key investment decision makers from family offices.

Biotech Family Offices, moderated by Colin Widen (CEO, Boston Innovation Capital), features:

Medtech Family Offices, moderated by Michael Quigley (VP of Market Research, Life Science Nation), features:

To catch this rare opportunity to meet family office investors with a focus on early stage life science investment, register for RESI now.

RESI Partnering Opens Monday 5/22 – The Early Entrepreneur Gets the Meetings

18 May

By Michael Quigley, VP of Market Research, LSN

mike-2RESI Partnering goes live on Monday, enabling fundraising life science executives and the investors who fund them to request meetings with one another on the basis of mutual fit. By getting into the system on day one you have the opportunity of being the first to request meetings, thus increasing your chances of being considered and getting the best meetings possible.

Powered by LSN’s proprietary investor data, the RESI partnering platform offers you something no other conference provider can, qualified forward-looking data on what investors are looking for. This data is one of several ingredients in RESI’s secret sauce that enables us to make so many meaningful connections (over 1500 per event!) between fundraising executives and investors.

Just getting in early isn’t enough to secure the most meaningful meetings as possible. We have been studying our partnering analytics since RESI 1, and after 12 RESI events we have proved that….big surprise….the more meeting requests you send out, the more meetings you will secure. The chart below shows the relationship between requests sent and meetings confirmed at a previous RESI event. Science and data minded folks, see for yourself!

And if all that isn’t enough to get you sign up, note that if you sign up by Friday May 19th you can beat the $200 price increase. I hope to see you all buzzing in the partnering hall in San Diego this June 19th.

Click Here to Register Now

Key Stakeholders Share the Value of RESI for Early Stage Investors and Startups

27 Apr

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

In San Diego on June 19th, the Redefining Early Stage Investments (RESI) Conference will bring a new, early stage focused discussion venue for startups and investors who are visiting BIO week and want more opportunities to connect. What makes RESI different? At our last event, RESI on MaRS in Toronto, we asked our key stakeholders this question and here’s what they told us.

Ying Tam – Head of Digital Health – MaRS Discovery District

“All the research says that one of the critical elements for an entrepreneur ecosystem, especially in health, is funding and investment. It takes a long time to nurture a health company, to get it to market and commercialization and scale. So, investment is critical for the development of a startup in health. RESI brings in a whole set of investors from across North America and across the world.”

Rebecca Yu – Head of JLABS @ TorontoJohnson & Johnson Innovation JLABS

“RESI attracts many repeat attendees, and that speaks to me that there’s a story, there’s something here. There’s great stuff happening here for entrepreneurs. There’s early stage companies from across Canada, from pharmaceuticals to medical devices to consumer health, and of course there’s a big digital health and AI presence here in Toronto. That’s why JLABS and J&J are here. We play in all the sectors, we partner with different groups within this ecosystem, and we see LSN/RESI as a key partner as well, to bring investors to this ecosystem.”

Richard Soll – Senior Vice President, International Discovery Service Unit – WuXi AppTec

“The RESI conference is an opportunity to help out these early stage companies such that they can achieve inflection points. If I can identify companies early, then I might become a vendor of choice for them. Getting in early becomes an important objective for me. When I come to a conference like RESI, I come to these early stage companies who are really looking for partnering with investors here, but also get an opportunity to introduce WuXi to them as well.”

RESI attendees can book up to 16 meetings with investors in one day, right at the start of BIO Week. If you want to take this opportunity to start your BIO with a bang, register now.

%d bloggers like this: